iTeos Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
7.42 | 48.72 | -84.78% | 9.59 | -22.67% |
| P/S |
|
30.81 | 33.75 | -8.72% |
|
|
| P/BV |
|
0.6746 | 4.82 | -86% |
|
|
| P/FCF |
|
-4.89 | 61 | -108.02% |
|
|
| Ev/Ebitda |
|
-0.9925 | -22.17 | -95.52% |
|
|
| Ev/S |
|
11.35 | 22.56 | -49.7% |
|
|
| Ev/FCF |
|
-1.34 | 68.75 | -101.95% |
|
|
| E/P |
|
-0.2157 | 0.0178 | -1313.59% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1143.22 | 4.98 | -23070.41% | -356.67 | +220.52% |
| ROE |
|
-19.58 | 9.61 | -303.73% |
|
|
| ROA |
|
-16.87 | 0.3443 | -5001.24% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-894.34 | -25.17 | 3453.18% |
|
|
| ROCE |
|
-25.19 | 15.35 | -264.09% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0421 | -3.68 | -98.86% | -0.0144 | +192.76% |
| Nеt Debt/Ebitda |
|
1.7 | -3.44 | -149.53% |
|
|
| Debt/Ratio |
|
0.0091 | 0.1985 | -95.43% |
|
|
| Debt/Equity |
|
2.88 | 1.66 | 73.55% |
|
|
| Debt/Net Income |
|
-0.0538 | 10.32 | -100.52% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.498 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-96.34 | -56.89 | 69.34% | ||
| Growth impulse Ebitda in 5 years |
|
595.55 | -54.68 | -1189.16% | ||
| Growth impulse Net Income in 5 years |
|
401.66 | -58.33 | -788.6% | ||
| Growth impulse FCF in 5 years |
|
347.17 | -49.48 | -801.64% | ||
| Growth impulse EPS in 5 years |
|
39.04 | -32.41 | -220.46% |
IP Score
4.33/10
